A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
Eleni M. Karapanagiotou, Adrianni Charpidou, Ifigenia Tzannou, Kalliopi Dilana, Elias Kotteas, Ioannis Tourkantonis, Epaminondas Kosmas, Aspasia Provata, Kostas SyrigosVolume:
25
Language:
english
Pages:
6
DOI:
10.1007/s12032-007-9036-9
Date:
September, 2008
File:
PDF, 159 KB
english, 2008